Indication:

Sitaglip® is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 Diabetes Mellitus.

Dosage & Administration:

The recommended dose of Sitaglip® is 100 mg once daily. Sitaglip® can be taken with or without food.
For patients with mild renal insufficiency (creatinine clearance [CrCl] 50 mL/min) no dosage adjustment for Sitaglip® is required.
For patients with moderate renal insufficiency (CrCl 30 to < 50 mL/min), the dose of Sitaglip® is 50 mg once daily.
For patients with severe renal insufficiency (CrCl < 30 mL/min) or with end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis, the dose of Sitaglip® is 25 mg once daily.
Sitaglip® may be administered without regard to the timing of hemodialysis.

Preparation:

Sitaglip®50 Tablet: Box containing 10 x 10 tablets in alu-alu blister pack.
Sitaglip®100 Tablet: Box containing 10 x 10 tablets in alu-alu blister pa